Identification of SARS-CoV-2 main protease inhibitors from FDA-approved drugs by artificial intelligence-supported activity prediction system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of SARS-CoV-2 main protease inhibitors from FDA-approved drugs by artificial intelligence-supported activity prediction system

Published:2022-01-05 Issue:5 Volume:41 Page:1767-1775
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Komatsu Hirotsugu¹^ORCID,Tanaka Takeshi¹,Ye Zhengmao¹,Ikeda Ken¹,Matsuzaki Takao¹,Yasugi Mayo²³⁴,Hosoda Masato¹

Affiliation:

1. Interprotein Corporation, Osaka, Japan

2. Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka, Japan

3. Asian Health Science Institute, Osaka Prefecture University, Izumisano, Osaka, Japan

4. Osaka International Research Center for Infectious Diseases, Osaka Prefecture University, Osaka, Japan

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2021.2024260

Reference33 articles.

1. Pharmacokinetics of vorapaxar and its metabolite following oral administration in healthy Chinese and American subjects

2. A review on drug repurposing applicable to COVID-19

3. Potential drug development and therapeutic approaches for clinical intervention in COVID-19

4. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Algorithms Developed for Rapid Pathogen Detection and Surveillance;Surveillance, Prevention, and Control of Infectious Diseases;2024

2. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review;European Journal of Medicinal Chemistry;2023-11

3. Antiviral activity of curcumin and its analogs selected by an artificial intelligence-supported activity prediction system in SARS-CoV-2-infected VeroE6 cells;Natural Product Research;2023-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3